3.2.5 Therapeutic Drug Monitoring Market, Germany, Revenue ($m), by Segment, 2014-2021
3.2.6 Urine Analysis Market, Germany, Revenue ($m), by Segment, 2014-2021
3.3 Clinical Chemistry Market, Germany, Distribution Share by Revenue ($m), 2013-2014
3.4 Clinical Chemistry Market, Germany, Company Share by Revenue ($m), 2014
4 Overview of Key Companies in Germany, Clinical Chemistry Market
4.1 Siemens Healthcare
4.1.1 Company Overview
4.2 F. Hoffmann-La Roche Ltd.
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 Ortho-Clinical Diagnostics Inc.
4.4.1 Company Overview
4.5 Mindray Medical International Limited
4.5.1 Company Overview
4.6 ELITech Group
4.6.1 Company Overview
5 Clinical Chemistry Market Pipeline Products
6 Financial Deals Landscape
6.1.1 NoemaLife Enters into Distribution Agreement with Horiba Medical
6.1.2 Metabolon Enters into Co-Marketing Agreement with Metdia Biotech
6.2 Venture Financing
6.2.1 Ayoxxa Biosystems Raises USD2.9 Million in Extended Series B Venture Financing
7 Recent Developments
7.1 Financial Announcements
7.1.1 Apr 28, 2015: Analytik Jena Enjoying Solid Start to New Financial Year
7.1.2 Apr 22, 2015: Noxilizer and Getinge-La Calhene announce exclusive global supply agreement for Noxilizer to provide NOX FLEX Rapid Biodecontamination systems for Getinge isolators - providing a new solution for the bio-pharmaceutical industry
7.1.3 Mar 30, 2015: 100th Patent in Three Years: The Result of a Successful Patent Strategy
7.1.4 Mar 26, 2015: Rockwell Medical Announces Triferic Clinical Data Selected for Four Poster Presentations at National Kidney Foundation Spring Clinical Meetings March 26-29, 2015 in Dallas, Texas
7.1.5 Mar 26, 2015: Eckert & Ziegler’s Annual Report 2014: Weak Therapy segment puts a strain on consolidated profit
7.1.6 Feb 04, 2015: Drug-eluting technologies for PAD treatments take centre stage at LINC 2015
7.1.7 Nov 27, 2014: Analytik Jena Devaluation Of The Ruble Necessitates Value Adjustment In The Project Business And Leads To A Clearly Negative Operating Result
7.2 Other Significant Developments
7.2.1 Feb 17, 2015: SGS Introduces Amino Acid Analytical Services At Its Taunusstein, Germany, Facility
7.2.2 Jan 16, 2015: Agilent Technologies Names Alacris Theranostics as Certified Provider of Target Enrichment Services
7.3 Product News
7.3.1 Apr 27, 2015: Analytik Jena Launches New Gene Assembly Robot at SynBioBETA London 2015
7.3.2 Jan 21, 2015: Analytik Jena Launches CE IvD Kits for Dementia Diagnostics
7.4 Strategy And Business Planning
7.4.1 Nov 06, 2014: Analytik Jena Establishes Subsidiary in India
GlobalData’s new report, Germany Clinical Chemistry Market Outlook to 2021, provides key market data on the Germany Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.
The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.
Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
2014 company shares and distribution shares data for Clinical Chemistry market.
Global corporate-level profiles of key companies operating within the Germany Clinical Chemistry market.
Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc.
Reasons to buy
Develop business strategies by identifying the key market segments poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.